ArticleMolecular cancer2015

Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas.

S Kreuz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.